Latest Boardroom Shifts News

Great Northern Minerals Limited reports significant progress in the sale of its Golden Ant Mining project, with a $1.3 million Earn-In Stage payment expected soon, alongside notable board changes and strategic project reviews.

Prescient Therapeutics has secured FDA clearance for its PTX-100 Phase 2 trial targeting relapsed/refractory cutaneous T-cell lymphoma, while also appointing James McDonnell as its new CEO. The company reports steady progress in its cell therapy platforms and maintains a solid cash position bolstered by a recent R&D tax rebate.

High-Tech Metals Limited intensifies its exploration efforts at the Werner Lake Project in Canada while appointing Warren Thorne as CEO to spearhead growth and asset acquisition strategies.

Range International Limited has appointed Russell Kennett as its new CEO, marking a pivotal step in the company’s growth strategy. The move comes alongside an update to Executive Chairman Richard Jenkins’ remuneration, underscoring leadership continuity.

Epsilon Healthcare's December 2023 quarterly report reveals significant boardroom conflict and governance breaches, yet operational segments show promising growth.

LCL Resources has executed a binding agreement to divest its Colombian assets for A$10 million, while confirming a significant copper-gold porphyry discovery at its Dada project in Papua New Guinea.

GWR Group Limited reports completion of phase two drilling at its Prospect Ridge Magnesium Project with assay results pending, while divesting its Hatches Creek interest to bolster focus and capital for growth.

PVW Resources has made significant progress in its Brazilian rare earths exploration at the Capão Bonito project, while also announcing the appointment of Lucas Stanfield as its new CEO. The company continues to focus on critical minerals and gold projects across multiple jurisdictions.

Lykos Metals Limited reports significant high-grade mineral findings at its Sinjakovo Project and extends its Jezero exploration permit, alongside key board appointments and cost restructuring.

BOA Resources Limited reveals its strategic drilling plans for 2025 targeting key lithium and nickel tenements in Western Australia, alongside a refreshed board and ongoing asset optimisation.

Emyria Limited reports strong progress in its MDMA and psilocybin-assisted therapy programs alongside a successful $2.525 million capital raise, positioning the company for expanded mental health treatment services.

Corella Resources reports promising rare earth element drilling results at its Tampu Project alongside significant board and management changes, while facing tight cash reserves.